ABAT |
GABA-transaminase deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✗ |
ABCA12 |
Ichthyosis |
16 |
0.00670017 |
0.0133106 |
0.000177171 |
✓ |
ABCA4 |
Retinal dystrophy |
53 |
0.0221943 |
0.0434034 |
0.00188386 |
✓ |
ABCC6 |
Pseudoxanthoma elasticum |
11 |
0.00460637 |
0.00917029 |
0.0000841 |
✓ |
ABCC8 |
Hyperinsulinism |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ABCG8 |
Sitosterolemia 1 |
10 |
0.0041876 |
0.00834014 |
0.0000696 |
✓ |
ACAD8 |
Isobutyryl-CoA dehydrogenase deficiency |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ACADM |
Acyl-CoA dehydrogenase |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ACADS |
Short-chain acyl-CoA-dehydrogenase deficiency |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
ACADSB |
Inborn error of metabolism |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ACADVL |
Very long chain acyl-CoA dehydrogenase deficiency |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
ACO2 |
Optic atrophy 9 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ADA |
Adenosine deaminase deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ADA2 |
Sneddon syndrome |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
ADAMTS13 |
Reduced expression |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ADAMTS17 |
Weill-Marchesani syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ADAMTS18 |
Microcornea, myopic chorioretinal atrophy and telecanthus |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
ADGRV1 |
Deafness, non-syndromic, autosomal recessive |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
AGK |
Sengers syndrome |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
AGL |
Glycogen storage disease 3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
AGRN |
Congenital myasthenic syndrome with distal muscle weakness & atrophy |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
AGXT |
Hyperoxaluria |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
AHI1 |
Joubert syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
AIPL1 |
Leber congenital amaurosis IV |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
AIRE |
Autoimmune polyendocrinopathy syndrome |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
AKR1D1 |
Bile acid synthesis defect |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ALDH3A2 |
Sjogren-Larsson syndrome |
15 |
0.00628141 |
0.0124839 |
0.000155848 |
✓ |
ALDH7A1 |
Epilepsy |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
ALDOB |
Fructose intolerance |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
ALG1 |
Congenital disorder of glycosylation |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ALG2 |
Congenital disorder of glycosylation 1i |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ALG3 |
Congenital disorder of glycosylation |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ALG8 |
Congenital disorder of glycosylation 1h |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ALMS1 |
Alstrom syndrome |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
ALPL |
Odontohypophosphatasia |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
ANO10 |
Cerebellar ataxia 3 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ANO5 |
Muscular dystrophy, limb girdle 2L |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
ANTXR2 |
Hyaline fibromatosis syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
AP4S1 |
Spastic paraplegia 52 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
APTX |
Ataxia |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
ARSA |
Metachromatic leukodystrophy |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ARSB |
Mucopolysaccharidosis type VI (Maroteaux-Lamy) |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ASAH1 |
Spinal muscular atrophy with progressive myoclonic epilepsy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ASL |
Argininosuccinic aciduria |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ASPM |
Microcephaly 5 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ATM |
Ataxia-telangiectasia |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
ATP13A2 |
Kufor-Rakeb syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ATP2A1 |
Autism spectrum disorder |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
ATP7B |
Wilson disease |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
ATP9A |
Neurodevelopmental disorder with poor growth and behavioral abnormalities |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ATR |
Pulmonary fibrosis / aplastic anaemia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
AVIL |
Nephrotic syndrome |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
B3GALNT2 |
Muscular dystrophy-dystroglycanopathy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
B3GALT6 |
Spondyloepimetaphyseal dysplasia with joint laxity |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
B3GAT3 |
Multiple joint dislocations |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
B3GLCT |
Peters-Plus syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
B4GALNT1 |
Spastic paraplegia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
BBS5 |
Phenotype modifier |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
BBS7 |
Bardet-Biedl syndrome, modifier of |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
BBS9 |
Retinitis pigmentosa |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
BCHE |
Butyrylcholinesterase deficiency |
29 |
0.0121441 |
0.0239932 |
0.000575671 |
✓ |
BCS1L |
GRACILE syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
BLM |
Breast cancer |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
BTD |
Biotinidase deficiency |
17 |
0.00711893 |
0.0141365 |
0.000199841 |
✓ |
C2CD3 |
Autism spectrum disorder |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
C5 |
Complement C5 deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
C6 |
Inflammatory bowel disease, very early onset |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
C7 |
Alzheimer disease in Han Chinese, association with |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
C8A |
Complement C8 alpha-gamma deficiency |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
C8B |
Primary immunodeficiency disease |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
CA5A |
Carbonic anhydrase VA deficiency |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
CABP4 |
Retinal dystrophy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CAPN3 |
Muscular dystrophy, limb girdle 2A |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
CBS |
Homocystinuria |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
CCDC103 |
Primary ciliary dyskinesia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CCDC39 |
Primary ciliary dyskinesia |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
CCDC40 |
Primary ciliary dyskinesia |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
CCN6 |
Pseudorheumatoid dysplasia, progressive |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CCNO |
Ciliary dyskinesia |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
CD36 |
Platelet glycoprotein IV deficiency |
41 |
0.0171692 |
0.0337488 |
0.00113898 |
✓ |
CDH23 |
Usher syndrome |
11 |
0.00460637 |
0.00917029 |
0.0000841 |
✓ |
CDH3 |
Hypotrichosis |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
CDK5RAP2 |
Autism spectrum disorder |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
CENPJ |
Intellectual disability |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CEP152 |
Seckel syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CEP290 |
Leber congenital amaurosis 10 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
CERS3 |
Ichthyosis |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
CFAP410 |
Retinitis pigmentosa |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
CFAP53 |
Dextrocardia and situs disturbances |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
CFTR |
Cystic fibrosis |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
CHRNE |
Congenital myasthenic syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CHRNG |
Multiple pterygium syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
CLCNKB |
Bartter syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CLMP |
Congenital short-bowel syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CLN3 |
Retinal dystrophy, early-onset |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
CNGA3 |
Achromatopsia 2 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
CNGB3 |
Achromatopsia 3 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
CNTN2 |
Hypogonadotropic hypogonadism |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
CNTNAP1 |
Hypomyelinating neuropathy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
COG7 |
Schizophrenia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
COL17A1 |
Epithelial recurrent erosion dystrophy |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
COL18A1 |
Knobloch syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
COL27A1 |
Steel syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
COL6A2 |
Bethlem myopathy 1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
COL7A1 |
EBD |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
COQ9 |
Primary coenzyme Q10 deficiency, neonatal onset |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
CORO1A |
Haemophagocytic lymphohistiocytosis |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
COX15 |
Hypertrophic cardiomyopathy, early onset |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
COX20 |
Dysarthria, ataxia and sensory neuropathy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CPLANE1 |
Joubert syndrome |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
CRB1 |
Leber congenital amaurosis 8 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CRB2 |
Congenital nephrosis, Finnish type-like, with cerebral ventriculomegaly & raised alpha-fetoprotein |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CRIPT |
Short stature, microcephaly & dysmorphic facies |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
CTNS |
Cystinosis |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
CTSK |
Pycnodysostosis |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
CUBN |
Albuminuria, association with |
52 |
0.0217755 |
0.0426027 |
0.00181499 |
✓ |
CUL7 |
3-M syndrome 1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
CYP11B1 |
Steroid-11 beta-hydroxylase deficiency |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
CYP1B1 |
Glaucoma 3A |
27 |
0.0113065 |
0.0223574 |
0.000499853 |
✓ |
CYP21A2 |
Hyperandrogenism |
135 |
0.0565327 |
0.106673 |
0.0113792 |
✓ |
CYP27A1 |
Cerebrotendinous xanthomatosis |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
CYP4V2 |
Retinitis pigmentosa |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
DARS2 |
Leukoencephalopathy with brainstem & spinal cord involvement |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
DGAT1 |
Diarrhea |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
DGUOK |
Portal hypertension |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
DHODH |
Miller syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
DLL3 |
Congenital scoliosis |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
DNAAF1 |
Neural tube defects |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
DNAH11 |
Ciliary dyskinesia |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
DNAH5 |
Primary ciliary dyskinesia |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
DNAH9 |
Situs inversus and male infertility |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
DNASE1L3 |
Systemic lupus erythematosus 16 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
DOCK6 |
Adams-Oliver syndrome 2 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
DOCK8 |
Immunodeficiency, primary |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
DOK7 |
Fetal akinesia deformation sequence 3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
DONSON |
Microcephaly |
23 |
0.00963149 |
0.0190775 |
0.000363949 |
✓ |
DPAGT1 |
Congenital disorder of glycosylation 1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
DPYD |
Dihydropyrimidine dehydrogenase deficiency |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
DPYS |
Dihydropyrimidinase deficiency |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
DSP |
Cardiomyopathy, arrhythmogenic right ventricular |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
DUOX2 |
Hypothyroidism |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
DYNC2H1 |
Asphyxiating thoracic dystrophy |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
DYNC2I1 |
Short-rib thoracic dysplasia 8 with or without polydactyly |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ECEL1 |
Arthrogryposis |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ECHS1 |
Short-chain enoyl-CoA hydratase deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
EDARADD |
Ectodermal dysplasia 11A |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ELP1 |
Autism spectrum disorder |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
EPG5 |
Vici syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ERCC2 |
Basal cell carcinoma, reduced risk, association with |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ESPN |
Hearing loss |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
EVC2 |
Ellis-van Creveld syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
EXOSC3 |
Pontocerebellar hypoplasia 1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
EXPH5 |
Epidermolysis bullosa, junctional |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
EYS |
Retinitis pigmentosa |
15 |
0.00628141 |
0.0124839 |
0.000155848 |
✓ |
F11 |
Factor XI deficiency |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
F2 |
Thrombophilia 1 due to thrombin defect |
22 |
0.00921273 |
0.0182557 |
0.000333271 |
✓ |
F7 |
Factor VII deficiency |
18 |
0.00753769 |
0.0149617 |
0.000223854 |
✓ |
FA2H |
Spastic paraplegia 35 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
FAH |
Tyrosinemia |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
FAM161A |
Retinitis pigmentosa |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
FANCC |
Fanconi anemia |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
FBP1 |
Fructose-1,6-bisphosphatase deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
FBXO7 |
Parkinsonism, juvenile |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
FH |
Multiple leiomyomatosis |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
FIG4 |
Amyotrophic lateral sclerosis, sporadic |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
FLVCR1 |
Posterior column ataxia & retinitis pigmentosa |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
FOXRED1 |
Complex I deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
FRAS1 |
Congenital anomalies of the kidney and urinary tract |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
FRRS1L |
Intellectual disability, developmental delay & seizures |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
FTCD |
Formiminoglutamic acidura |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
G6PC1 |
Glycogen storage disease Ia |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
GAA |
Glycogen storage disease II |
10 |
0.0041876 |
0.00834014 |
0.0000696 |
✓ |
GALC |
Krabbe disease |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
GALK1 |
Galactokinase deficiency, presenile cataract |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
GALNS |
Mucopolysaccharidosis IVA |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
GALNT3 |
Tumoral calcinosis |
16 |
0.00670017 |
0.0133106 |
0.000177171 |
✓ |
GAMT |
Cerebral creatine deficiency syndrome 2 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
GBA |
Gaucher disease |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
GBA2 |
Spastic paraplegia |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
GBE1 |
Glycogen storage disease 4 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
GCDH |
Glutaric acidaemia 1 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
GDAP1 |
Charcot-Marie-Tooth disease |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
GFPT1 |
Congenital myasthenic syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
GHR |
Hypogonadotropic hypogonadism |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
GIPC3 |
Hearing loss, non-syndromic |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
GJB2 |
Keratoderma |
30 |
0.0125628 |
0.02481 |
0.000615535 |
✓ |
GLB1 |
GM1-gangliosidosis |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
GLDC |
Glycine encephalopathy |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
GNE |
GNE myopathy |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
GNPTAB |
Mucolipidosis III alpha/beta |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
GNRHR |
Hypogonadotropic hypogonadism |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
GP6 |
Absence of collagen-induced platelet activation |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
GPHN |
Hyperekplexia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
GPR179 |
Autism spectrum disorder |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
GRHPR |
Hyperoxaluria II |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
GRM6 |
Congenital stationary night blindness |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
GYS2 |
Glycogen storage disease 0 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
HADHB |
Mitochondrial trifunctional protein deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
HBA1 |
Haemoglobin variant |
34 |
0.0142379 |
0.0280703 |
0.000787941 |
✓ |
HBA2 |
Haemoglobin variant |
22 |
0.00921273 |
0.0182557 |
0.000333271 |
✓ |
HBB |
Haemoglobin variant |
121 |
0.05067 |
0.0962051 |
0.00925543 |
✓ |
HBD |
Haemoglobin variant |
31 |
0.0129816 |
0.0256261 |
0.000656697 |
✓ |
HEXA |
[Hex A pseudodeficiency] |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
HGD |
Alkaptonuria |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
HGSNAT |
Mucopolysaccharidosis type IIIC (Sanfilippo C) |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
HPS3 |
Hermansky-Pudlak syndrome 3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
HSD11B2 |
Apparent mineralocorticoid excess |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
HSD17B3 |
Pseudohermaphroditism, male |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
HSD17B4 |
D-bifunctional protein deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
HSPG2 |
Scoliosis, idiopathic, association with |
14 |
0.00586265 |
0.0116566 |
0.000135875 |
✓ |
IDUA |
Hurler syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
IFT140 |
Leber congenital amaurosis |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
IL12RB1 |
Mycobacterial infection |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
IL17RA |
IL-17RA deficiency with bacterial and fungal infections |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
INPP5E |
Joubert syndrome 1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
IQCB1 |
Leber congenital amaurosis |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
ITGB2 |
Leukocyte adhesion deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ITGB3 |
Bleeding disorder |
15 |
0.00628141 |
0.0124839 |
0.000155848 |
✓ |
ITGB4 |
Hirschsprung disease |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
IVD |
Isovaleric acidemia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
IYD |
Hypothyroidism |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
JAK3 |
Immunodeficiency, severe combined |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
KCNJ1 |
Bartter syndrome |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
KCNV2 |
Retinal cone dystrophy 3B |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
KIAA0586 |
Joubert syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
KIF1C |
Cerebellar ataxia |
10 |
0.0041876 |
0.00834014 |
0.0000696 |
✓ |
KIF7 |
Macrocephaly, multiple epiphyseal dysplasia & facial features |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
KLHL7 |
Retinitis pigmentosa 42 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
LAMA1 |
Schizophrenia |
9 |
0.00376884 |
0.00750928 |
0.0000564 |
✓ |
LAMA3 |
Epidermolysis bullosa, junctional |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
LAMB2 |
Pierson syndrome/ nephrotic syndrome type 5 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
LAMC2 |
Epidermolysis bullosa, Herlitz |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
LDLR |
LDL cholesterol level QTL2 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
LHX3 |
Hypopituitarism and sensorineural hearing loss |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
LIFR |
Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
LIG4 |
Marfan syndrome, early-onset |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
LINS1 |
Intellectual developmental disorder |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
LMAN1 |
Factor V and factor VIII deficiency, combined |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
LMBR1 |
Triphalangeal thumbs and preaxial polydactyly |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
LMNA |
Mandibuloacral dysplasia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
LOXHD1 |
Deafness |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
LOXL3 |
Myopia 28 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
LPL |
Hyperlipidaemia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
LRPPRC |
Infantile mitochondrial disease, lethal |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
LRRK1 |
Osteosclerotic metaphyseal dysplasia |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
LYST |
Chediak-Higashi syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
MALT1 |
Immunodeficiency, combined |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
MAPKBP1 |
Nephronophthisis, late onset |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
MCIDAS |
Ciliary dyskinesia |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
MEFV |
Neutrophilic dermatosis |
73 |
0.0305695 |
0.05927 |
0.00351294 |
✓ |
MKS1 |
Parkinson disease, early onset |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
MMACHC |
Methylmalonic aciduria and homocystinuria |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
MMADHC |
Homocystinuria, cblD type |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
MMUT |
Methylmalonic aciduria |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
MOCOS |
Thiopurine-induced toxicity |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
MPL |
Thrombocytosis, association with |
9 |
0.00376884 |
0.00750928 |
0.0000564 |
✓ |
MPLKIP |
Trichothiodystrophy, nonphotosensitive |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
MPV17 |
Mitochondrial DNA depletion syndrome, hepatocerebral |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
MRE11 |
Breast cancer |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
MTRR |
Cleft lip with or without cleft palate |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
MVK |
Hyper-IgD syndrome |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
MYO15A |
Deafness, non-syndromic, autosomal recessive |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
MYO5B |
Diarrhea 2 |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
NBAS |
Bone, connective tissue, liver, immune system & retinal defects |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
NBN |
Breast cancer, male |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
NCF1 |
Chronic granulomatous disease |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
NCF2 |
Chronic granulomatous disease |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
NDUFAF5 |
Leigh syndrome/Mitochondrial Complex I deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
NDUFS1 |
Neurodevelopmental disorder |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
NEK1 |
Amyotrophic lateral sclerosis |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
NEK8 |
Renal disease with hepatic and cardiac anomalies |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
NKX6-2 |
Spastic ataxia 8 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
NPHP1 |
Nephronophthisis 1 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
NPHP4 |
Nephronophthisis 4 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
NPHS1 |
Nephrotic syndrome |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
NR2E3 |
Retinitis pigmentosa 37 |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
NUBPL |
Complex I deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
OBSL1 |
Cardiomyopathy, dilated |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
OCLN |
Pseudo-TORCH syndrome 1 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
OPA1 |
Optic atrophy plus syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ORC4 |
Lymphoproliferative disorder |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
ORC6 |
Meier-Gorlin syndrome |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
OTOA |
Hearing loss |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
OTOF |
Deafness, non-syndromic |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
OTOG |
Hearing loss, sensorineural |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
OTOGL |
Hearing impairment |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
PAH |
Hyperphenylalaninemia |
40 |
0.0167504 |
0.0329397 |
0.00108502 |
✓ |
PANK2 |
Neurodegeneration with brain iron accumulation 1 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
PC |
Hyperinsulinism |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PCARE |
Retinitis pigmentosa 54 |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
PCCB |
Propionicacidemia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PCDH15 |
Usher syndrome 1 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
PDE6B |
Retinitis pigmentosa, pericentral |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PDP1 |
Tourette syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PEPD |
Prolidase deficiency |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
PEX1 |
Zellweger syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
PEX12 |
Peroxisome biogenesis disorder 3B |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PEX16 |
Peroxisome biogenesis disorder 8B |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PEX26 |
Refsum disease, infantile |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PEX6 |
Peroxisome biogenesis disorder 4B |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
PGM1 |
Congenital disorder of glycosylation |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PGM3 |
Fetal alcohol syndrome, predisposition to |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
PHC1 |
Primary microcephaly |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
PHGDH |
Neu-Laxova syndrome 1 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PIGO |
PIGO deficiency |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
PJVK |
Deafness |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
PKHD1 |
Polycystic kidney disease 4 |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
PKLR |
Pyruvate kinase deficiency |
18 |
0.00753769 |
0.0149617 |
0.000223854 |
✓ |
PLA2G6 |
Infantile neuroaxonal dystrophy |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
PLEKHG5 |
Myopathy |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
PLOD1 |
Ehlers-Danlos syndrome |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
PMM2 |
Congenital disorder of glycosylation 1a |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
PNP |
Nucleoside phosphorylase deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PNPO |
Pyridoxamine 5'-phosphate oxidase deficiency |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
POLG |
Mitochondrial recessive ataxia syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
POR |
Altered function |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PRG4 |
Camptodactyly-arthropathy-coxa vara-pericarditis syndrome |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
PRICKLE1 |
Neural tube defects |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PROC |
Thrombophilia 3 due to protein C deficiency |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
PRUNE1 |
Hypotonia, microcephaly and global developmental delay |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PSAP |
Combined SAP deficiency |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
PSAT1 |
Developmental disorder |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
PTPRQ |
Congenital sensorineural hearing loss, autosomal recessive |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
PTS |
Tetrahydrobiopterin deficiency |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
PYGL |
Glycogen storage disease 6 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
PYGM |
McArdle disease |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
QARS1 |
Microcephaly |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
QDPR |
Dihydropteridine reductase deficiency |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
RAB3GAP2 |
Microphthalmia & cataract |
10 |
0.0041876 |
0.00834014 |
0.0000696 |
✓ |
RAG1 |
Omenn syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
RAPSN |
Congenital myasthenic syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
RARS2 |
Pulmonary arterial hypertension |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
RAX |
Microphthalmia |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
RECQL4 |
Baller-Gerold syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
RFXANK |
MHC class II deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
RNASEH2A |
Aicardi-Goutieres syndrome 4 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
RNASEH2B |
Aicardi-Goutières syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
RNASEH2C |
Aicardi-Goutieres syndrome 3 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ROBO3 |
Gaze palsy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ROGDI |
Kohlschütter-Tönz syndrome |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
RPGRIP1 |
Cone-rod dystrophy 13 |
11 |
0.00460637 |
0.00917029 |
0.0000841 |
✓ |
RTTN |
Primary microcephaly & primordial dwarfism |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
RYR1 |
Congenital myopathy 1B |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
SACS |
Spastic ataxia, Charlevoix-Saguenay |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
SAG |
Retinitis pigmentosa, autosomal recessive |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
SBDS |
Shwachman-Diamond syndrome |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
SBF1 |
Charcot-Marie-Tooth disease |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
SCN4A |
Paramyotonia congenita |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
SCN9A |
Childhood absence epilepsy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SEC23B |
Anaemia, dyserythropoietic congenital, type II |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
SEPSECS |
Cerebellar atrophy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SERPINA1 |
Reduced alpha-1-antitrypsin concentration |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
SERPINF1 |
Osteogenesis imperfecta |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
SGCD |
Muscular dystrophy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SGCG |
Muscular dystrophy, limb girdle |
32 |
0.0134003 |
0.0264415 |
0.000699155 |
✓ |
SGSH |
Mucopolysaccharidosis type IIIA (Sanfilippo A) |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SI |
Sucrase isomaltase deficiency |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
SKIV2L |
Macular degeneration, age related, reduced risk |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
SLC12A3 |
Gitelman syndrome |
8 |
0.00335008 |
0.00667772 |
0.0000446 |
✓ |
SLC19A3 |
Wernicke's-like encephalopathy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SLC22A5 |
Carnitine deficiency |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SLC25A13 |
Intrahepatic cholestasis, neonatal |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
SLC25A19 |
Thiamine metabolism dysfunction syndrome 4 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SLC25A20 |
Carnitine-acylcarnitine translocase deficiency |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
SLC26A4 |
Deafness |
19 |
0.00795645 |
0.0157863 |
0.000249207 |
✓ |
SLC2A1 |
Glucose transporter type 1 deficiency syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SLC34A1 |
?Fanconi renotubular syndrome 2 |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
SLC35D1 |
Schneckenbecken dysplasia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SLC37A4 |
Glycogen storage disease 1b |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
SLC38A8 |
Foveal hypoplasia, optic nerve decussation defects and anterior segment dysgenesis |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SLC39A14 |
?Hyperostosis cranalis interna |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SLC3A1 |
Cystinuria |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
SLC5A7 |
Neuronopathy |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
SLC6A19 |
Hartnup disorder |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
SMPD1 |
Niemann-Pick disease |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
SORD |
Neuronopathy, distal hereditary motor, autosomal recessive 8 |
12 |
0.00502513 |
0.00999975 |
0.0001 |
✓ |
SPATA7 |
Leber congenital amaurosis 3 |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
SPG11 |
Charcot-Marie-Tooth disease |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
SPG7 |
Spastic paraplegia |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
SPTA1 |
Spherocytosis |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
STRC |
Deafness, non-syndromic |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
SVBP |
Neurodevelopmental disorder with ataxia |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
TGM1 |
Ichthyosiform erythroderma, congenital, nonbullous |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
THOC6 |
Intellectual disability |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
TMC1 |
Deafness |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
TMCO1 |
Cerebro-facio-thoracic dysplasia |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
TMEM107 |
Oral-facial-digital syndrome |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
TMEM138 |
Joubert syndrome 16 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
TMEM231 |
Meckel syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
TMEM237 |
Joubert syndrome related disorder |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
TMEM67 |
Nephronophthisis 11 |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
TMPRSS3 |
Hearing loss |
4 |
0.00167504 |
0.00334447 |
0.0000112 |
✓ |
TPI1 |
Hemolytic anemia due to triosephosphate isomerase deficiency |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
TPO |
Thyroid dyshormonogenesis 2A |
15 |
0.00628141 |
0.0124839 |
0.000155848 |
✓ |
TPRN |
Hearing loss |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
TRAPPC9 |
Hypogonadotropic hypogonadism, normosmic |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
TRIOBP |
Developmental disorder |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
TRIP4 |
Spinal muscular atrophy & congenital bone fractures |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
TRMT10A |
Neurodevelopmental disorder |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
TRPM1 |
Night blindness |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
TSEN54 |
Intellectual disability & epilepsy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
TTC21B |
Bardet-Biedl syndrome |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |
TTC37 |
Fatigue, failure to thrive & diarrhoea |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
TTC7A |
Immunodeficiency, combined, with intestinal atresias |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
TTN |
Muscular dystrophy |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
TUBGCP6 |
Diaphragmatic hernia |
3 |
0.00125628 |
0.00250941 |
0.0000063 |
✓ |
TYR |
Albinism, oculocutaneous |
14 |
0.00586265 |
0.0116566 |
0.000135875 |
✓ |
UBR1 |
Johanson-Blizzard syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
UFSP2 |
?Hip dysplasia |
7 |
0.00293132 |
0.00584546 |
0.0000342 |
✓ |
UPB1 |
Beta-ureidopropionase deficiency |
10 |
0.0041876 |
0.00834014 |
0.0000696 |
✓ |
USH2A |
Retinitis Pigmentosa |
13 |
0.00544389 |
0.0108285 |
0.000117256 |
✓ |
VARS2 |
Mitochondrial encephalopathy |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
VDR |
Rickets |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
VPS13B |
Cohen syndrome |
5 |
0.0020938 |
0.00417884 |
0.0000175 |
✓ |
VPS33B |
Arthrogryposis, renal dysfunction and cholestasis |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
VPS53 |
Parkinson disease, early onset |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
VWF |
von Willebrand disease |
9 |
0.00376884 |
0.00750928 |
0.0000564 |
✓ |
WDR35 |
Short rib-polydactyly syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
WDR62 |
Microcephaly, primary |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
WHRN |
Usher syndrome |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
WRN |
Werner syndrome |
2 |
0.000837521 |
0.00167364 |
0.0000028 |
✓ |
XPNPEP3 |
NPHP-like kidney disease |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
XYLT1 |
Desbuquois dysplasia 2 |
1 |
0.00041876 |
0.00083717 |
0.000000701 |
✓ |
ZFYVE26 |
Spastic paraplegia with thin corpus callosum |
6 |
0.00251256 |
0.0050125 |
0.0000251 |
✓ |